Stuck in a village in southern India for nine months and unable to return to his job in Saudi Arabia, Sugathan P. R. is hoping the World Health Organisation will approve the Indian Covid-19 shot Covaxin, paving the way for his trip back.
Like Sugathan, millions of Indians have taken Covaxin and many have complained of travel struggles as the vaccine has not been recognised for international travel by several countries.
“I had the option of going to Saudi and taking (additional doses of) Covishield after a four-day institutional quarantine, but I was not sure of its implications on my health,” said Sugathan, referring to AstraZeneca's vaccine.
“If the Covaxin approval does not come, I will take the risk of going and taking a Saudi-approved vaccine,” he told Reuters, sitting in his spacious two-storey house fronted by paddy fields.
The WHO is expected to take a final call on an emergency-use listing for Covaxin on Tuesday (today).
